How many drugs treat COVID-19 prevention?

Drug Landscape tracks 10 marketed treatments for COVID-19 prevention (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/covid-19-prevention.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

COVID-19 prevention — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

COVID-19 prevention (disease) competitive landscape: 10 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

10 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating COVID-19 prevention, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target
Combination BNT162b2 and BNT162b2 OMI	combination-bnt162b2-and-bnt162b2-omi	Pfizer	mRNA vaccine	SARS-CoV-2 spike protein
BNT162b2	bnt162b2	Pfizer	vaccine	SARS-CoV-2 virus
BNT162b5 Bivalent (Original/OMI BA.4/BA.5)	bnt162b5-bivalent-original-omi-ba-4-ba-5	Pfizer	mRNA vaccine	Spike protein of SARS-CoV-2
BNT162b2 (Omi JN.1)	bnt162b2-omi-jn-1	Pfizer	unknown	unknown
BNT162b4 15 mcg	bnt162b4-15-mcg	Pfizer	Unknown	Unknown
Famtozinameran 12 Years of age and older	famtozinameran-12-years-of-age-and-older	Pfizer	monoclonal antibody	SARS-CoV-2 virus
BNT162b2 (2025/2026 formulation)	bnt162b2-2025-2026-formulation	Pfizer	vaccine	SARS-CoV-2 spike protein
BNT162b2 OMI	bnt162b2-omi	Pfizer	Not specified	Not specified
BNT162b4 5 mcg	bnt162b4-5-mcg	Pfizer	vaccine	SARS-CoV-2 spike protein
qIRV (22/23)	qirv-22-23	Pfizer	Unknown	Unknown

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Pfizer · 13 drugs in COVID-19 prevention

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in COVID-19 prevention:

Cite this brief

Drug Landscape (2026). COVID-19 prevention — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/covid-19-prevention. Accessed 2026-06-10.

COVID-19 prevention full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing